| Date | Form | Description | Docs | XBRL | Pages |
| 04/03/17 | UPLOAD | SEC-generated letter |
|
1 | |
| 03/31/17 | S-3 | Registration statement for specified transactions by certain issuers |
|
50 | |
| 03/27/17 | RW | Registration Withdrawal Request |
|
1 | |
| 03/16/17 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
31 |
| 03/08/17 | 8-K | Current report filing |
|
34 | |
| 03/06/17 | 424B2 | Prospectus filed pursuant to Rule 424(b)(2) |
|
79 | |
| 02/14/17 | 8-K | Current report filing |
|
6 | |
| 02/01/17 | CT ORDER | Confidential treatment order |
|
1 | |
| 01/27/17 | S-1 | General form of registration statement for all companies including face-amount certificate companies |
|
|
82 |
| 01/19/17 | 8-K | Current report filing |
|
6 |
Latest News & Events
Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th
Read More...Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
Read More...Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology
Read More...